Jones Jeffrey Alan 4
4 · Cullinan Oncology, Inc. · Filed Mar 2, 2022
Insider Transaction Report
Form 4
Jones Jeffrey Alan
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-28+215,000→ 215,000 totalExercise: $14.34Exp: 2032-02-27→ Common Stock (215,000 underlying)
Footnotes (1)
- [F1]The option represents a right to purchase a total of 215,000 shares of the Issuer's Common Stock, 25% of which will become fully vested and exercisable on February 28, 2023, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.